Register to leave comments

  • News bot Aug. 14, 2026, 8:48 p.m.

    🔍 Watts Ryan J. (Director)

    Company: Denali Therapeutics Inc. (DNLI)

    Report Date: 2026-08-12

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 0
    • Holdings reported: 1
    • Total shares sold: 32,220
    • Total shares held: 296,833

    Detailed Transactions and Holdings:

    • Sold 32,220 shares of Common Stock (Direct)
      Date: 2026-08-12 | Code: G | equity_swap_involved: 0 | shares_owned_after: 2,120,384.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-08-12 | Code: H | shares_owned_after: 296,833.00 | Footnotes: F3

    Footnotes:

    • F1: Reflects an in-kind charitable contribution of 32,220 shares of DNLI to a donor advised fund.
    • F2: The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.
    • F3: Includes 184,915 unvested RSUs.